GlassScriptPhysician profile
Edward Southard
NPI 1578799102
$18,760.53
in general payments reported to CMS, 2019-2025
12 companies · $2,486 in 2025
The $2,486 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,249 · 2020: $4,061 · 2021: $4,366 · 2022: $2,481 · 2023: $1,537 · 2024: $582 · 2025: $2,486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,030 · Food and Beverage: $1,575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,030.11 |
| Food and Beverage | $1,574.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $6,587.87 | 2019-2021 | |
| Arthrex, INC. | $6,367.44 | 2021-2025 | |
| Stryker Corporation | $1,761.12 | 2019-2024 | Mako, Aequalis Perform, Gamma |
| Southern Edge Orthopaedics, INC. | $1,337.05 | 2022-2023 | |
| Medical Device Business Services, INC. | $987.36 | 2019-2022 | |
| Team 1, LLC | $940.48 | 2021 | |
| Coastal Medical Technologies LLC | $417.33 | 2025 | |
| Zimmer Biomet Holdings, INC. | $122.43 | 2019 | |
| Depuy Synthes Sales INC. | $100.85 | 2020-2024 | Orthovisc, Monovisc |
| Smith+Nephew, INC. | $84.97 | 2022-2024 | Healicoil, Firstpass, Bone Anchors With Arthroscopic Delivery System |
| Solventum Corporation | $29.80 | 2025 | V.A.C. Granufoam, V.A.C.Ulta, Prevena |
| Davol INC. | $23.83 | 2025 | Phasix Mesh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Southard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.